55 results on '"P. Gosse"'
Search Results
2. Effect of telmisartan vs. ramipril on 'dipping' status and blood pressure variability: pooled analysis of the PRISMA studies.
3. Long-term influence of antihypertensive treatment on arterial stiffness assessed by ambulatory measurement of the QKD interval.
4. Highlights of the 2024 Chinese hypertension guidelines
5. Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials
6. Discrepancies between home blood pressure and ambulatory blood pressure monitoring in apparent treatment-resistant hypertension: analysis from the Korean resistant hypertension cohort
7. Long-term results of the RADIANCE-HTN TRIO trial: strengths and limitations
8. Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS)
9. Effects of renal denervation on the kidney: albuminuria, proteinuria, and renal function
10. Indications for renal denervation in the treatment of hypertension
11. Association of central arterial stiffness with atrial myopathy: the Atherosclerosis Risk in Communities (ARIC) study
12. Impact of renal denervation on quality of life (How does renal denervation contribute to improving hypertension treatment affected by poor medication adherence?)
13. Comparison of the effects of renal denervation at early or advanced stages of hypertension on cardiac, renal, and adipose tissue pathology in Dahl salt-sensitive rats
14. Effects of renal denervation on the incidence and severity of cardiovascular diseases
15. What are the ideal metrics for assessing the quality of long-term stabilized “perfect” 24-h BP control after renal denervation?
16. Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials
17. Does renal denervation require cardiovascular outcome-driven data?
18. Differences in the effectiveness and safety of different renal denervation devices
19. Renal denervation up-to-date 2024: evidence and perspectives in Japan
20. QKD interval as a noninvasive method for evaluation of atherosclerosis
21. Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension
22. Skin sodium content as a predictor of blood pressure response to renal denervation
23. Current problems in renal denervation and a hope to break the stage
24. Associations of blood pressure trajectories in early life with target organ damage in midlife : a 30-year cohort study
25. Arterial Hypertension—clinical trials update 2023
26. Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation
27. Hypertensive emergencies and urgencies: a preliminary report of the ongoing Italian multicentric study ERIDANO
28. Superselective adrenal arterial embolization for primary aldosteronism without lateralized aldosterone secretion: an efficacy and safety, proof-of-principle study
29. 2022 Renal denervation therapy for the treatment of hypertension: a statement from the Thai Hypertension Society
30. The intrarenal blood pressure modulation system is differentially altered after renal denervation guided by different intensities of blood pressure responses
31. Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
32. Technical aspects should also be fully considered in order to obtain better effectiveness of RDN
33. Intrarenal neurohormonal modulation by renal denervation: benefits for chronic kidney disease and heart failure
34. Update on Hypertension Research in 2021
35. 2022 Malaysian Working Group Consensus Statement on Renal Denervation for management of arterial hypertension
36. Arterial hypertension - clinical trials update 2022
37. Renal denervation: basic and clinical evidence
38. A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment
39. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials
40. Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial
41. Perspectives of renal denervation from hypertension to heart failure in Asia
42. Hypertension research from Japan: advancing the field of renal denervation
43. Renal denervation based on experimental rationale
44. Editorial comment: Renal denervation
45. Comparison of Brachial Blood Pressure and Central Blood Pressure in Attended, Unattended, and Unattended Standing Situations
46. A recent advance in Renal denervation to clinical practice
47. Contribution of single office aortic systolic blood pressure measurements to the detection of masked hypertension: data from two separate cohorts
48. Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria
49. Home-measured orthostatic hypotension associated with cerebral small vessel disease in a community-based older population
50. Genetic factors associated with elevation of uric acid after treatment with thiazide-like diuretic in patients with essential hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.